Distinct antibody profiles in HLA-B∗57+, HLA-B∗57- HIV controllers and chronic progressors

AIDS. 2022 Mar 15;36(4):487-499. doi: 10.1097/QAD.0000000000003080.

Abstract

Objective: Spontaneous control of HIV replication without treatment in HIV-1 controllers (HICs) was associated with the development of an efficient T-cell response. In addition, increasing data suggest that the humoral response participates in viral clearance.

Design: In-depth characterization of Ab response in HICs may help to define new parameters associated with this control.

Methods: We assessed the levels of total and HIV-specific IgA and IgG subtypes induction and their functional potencies - that is, neutralization, phagocytosis, antibody-dependent cellular cytotoxicity (ADCC), according to the individual's major histocompatibility complex class I (HLA)-B∗57 status, and compared it with nontreated chronic progressors.

Results: We found that despite an undetectable viral load, HICs displayed HIV-specific IgG levels similar to those of chronic progressors. Interestingly, our compelling multifunctional analysis demonstrates that the functional Ab profile, by itself, allowed to discriminate HLA-B∗57+ HICs from HLA-B∗57- HICs and chronic progressors.

Conclusion: These results show that HICs display a particular HIV-specific antibody (Ab) profile that may participate in HIV control and emphasize the relevance of multifunctional Ab response analysis in future Ab-driven vaccine studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • HIV Antibodies
  • HIV Infections*
  • HIV Non-Progressors
  • HIV-1*
  • HLA-B Antigens
  • Humans
  • Immunoglobulin G
  • Viral Load

Substances

  • HIV Antibodies
  • HLA-B Antigens
  • HLA-B57 antigen
  • Immunoglobulin G